Clinical Trials Directory

Trials / Completed

CompletedNCT04774211

Prospective Prevalence and Validation Study of Pediatric Intensive Care Delirium.

Status
Completed
Phase
Study type
Observational
Enrollment
141 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
3 Months – 18 Years
Healthy volunteers

Summary

Pediatric delirium (PD) is a poorly investigated clinical problem that needs to be further explored in a Danish context. Children are at risk of discomfort and suffering if they experience delirium. The condition is associated with prolonged mechanical ventilation, longer hospital stay, increased mortality, and risk of long-term cognitive impairment. Therefore, it is important to assess critically ill children with a validated tool to enable early detection and management of the condition. In this study, the investigators will determine the prevalence of pediatric intensive care delirium. To this end, the investigators will validate the Sophia Observation withdrawal Symptoms - Pediatric delirium scale (SOS-PD) for patient assessment.

Detailed description

Prospective prevalence and validation study of pediatric intensive care delirium. Aim: To validate the SOS-PD assessment tool and determine the prevalence of delirium in children aged 3 months to 18 years in a Danish context. Data analysis and power calculation: With 140 patients, the accuracy estimate in this study will have a 95% confidence interval of +/- 5%. Accuracy defined as (true positive + true negative) / all x 100 is expected to be 90%. The validity of the SOS-PD assessment tool is calculated from standard definitions of sensitivity, specificity, positive predictive value and negative predictive value. The prevalence is calculated in percent. All data will be entered and encoded in RedCap and exported to SPSS for statistical analysis of data.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSOS-PDValidation of SOS-PD bedside assessments comparing the Danish SOS-PD scale with a Child Psychiatrist using DSM-V as the reference standard

Timeline

Start date
2021-01-01
Primary completion
2022-06-30
Completion
2022-06-30
First posted
2021-03-01
Last updated
2022-08-31

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04774211. Inclusion in this directory is not an endorsement.